Prine Kelli Beckvermit, Goracke Kimberly, Rubarth Lori Baas
Neonatal Netw. 2015;34(3):183-8. doi: 10.1891/0730-0832.34.3.183.
Extracorporeal membrane oxygenation (ECMO) was developed for adults but has been used in neonates as a life-saving rescue therapy for infants with respiratory failure and/or cardiac collapse as a result of congenital diaphragmatic hernia, meconium aspiration syndrome, persistent pulmonary hypertension, or systemic sepsis. ECMO has been proven to increase the survival rate for these diseases. This article provides an overview of neonatal ECMO: the history and development of neonatal ECMO, patient selection criteria, clinical management, the ECMO circuit, weaning from ECMO, and possible complications of ECMO.
体外膜肺氧合(ECMO)最初是为成人开发的,但已被用于新生儿,作为一种挽救生命的治疗方法,用于治疗因先天性膈疝、胎粪吸入综合征、持续性肺动脉高压或全身性败血症导致呼吸衰竭和/或心脏骤停的婴儿。ECMO已被证明可提高这些疾病的存活率。本文概述了新生儿ECMO:新生儿ECMO的历史和发展、患者选择标准、临床管理、ECMO回路、ECMO撤机以及ECMO可能的并发症。